4-toluenesulfonamide has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LA; Guan, WJ; Han, BH; Hu, CP; Huang, J; Jin, FG; Li, HP; Li, Q; Li, SY; Liu, SZ; Wang, J; Wu, CG; Wu, GM; Xiang, Y; Xu, GL; Yang, HP; Zhao, JP; Zhong, NS; Zhou, X | 1 |
| Guan, Y; He, J; Jiang, M; Shao, W; Tucker, S; Wang, D; Wu, Y; Xu, X; Yang, H; Ying, W; Zhong, B; Zhong, N | 1 |
2 trial(s) available for 4-toluenesulfonamide and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial.
Topics: Adult; Aged; Aged, 80 and over; Airway Obstruction; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Injections, Intralesional; Lung Neoplasms; Male; Middle Aged; Severity of Illness Index; Sulfonamides; Survival Analysis; Toluene; Treatment Outcome; Young Adult | 2016 |
Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension.
Topics: Administration, Cutaneous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Quality of Life; Sulfonamides; Toluene; Treatment Outcome | 2009 |